Clinical trial
TNF in Melanoma Patients Treated With Immunotherapy
NCT03348891 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TNF in Melanoma Patients Treated With Immunotherapy
- Lead sponsor
- Institut Claudius Regaud
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 5, 2018
- Completion date
- November 22, 2021
- Enrollment
- 60 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.